To understand Key Opinion Leaders perspectives around the accessibility and acceptability of emerging treatment options along with GLP-1 agonists unmet need of current therapies Details on report methodology, top indications covered, market assumptions, patient journey and KOLs to strengthen the pharmaceutical companies development and launch strategy.
Microneedle patches deliver targeted GLP-1RAs-loaded nanoparticles for the treatment of rheumatoid arthritis
2024;187:294311 Chen H, Li Y, Li H, Chen X, Fu H, Mao D, et al
Diabetes Mellitus: a comprehensive review of types, pathophysiology, complications, and standards of care in diabetes 2025
Mucoadhesive vs
Side Effects: Muscle tissue is colored temporarily by this preparation